Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease

被引:51
|
作者
Blesa, Javier [1 ,2 ]
Juri, Carlos [1 ,3 ]
Garcia-Cabezas, Miguel A. [4 ,5 ]
Adanez, Rebeca [1 ,2 ]
Sanchez-Gonzalez, Miguel A. [4 ,5 ]
Cavada, Carmen [4 ,5 ]
Obeso, Jose A. [1 ,2 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada, Dept Neurol & Neurociugia, Lab Trastornos Movimiento,Neurociencias, Pamplona, Spain
[2] Inst Carlos III, Minist Ciencia & Innovat, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[4] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[5] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
来源
FRONTIERS IN SYSTEMS NEUROSCIENCE | 2011年 / 5卷
关键词
MPTP; Parkinson's disease; PET; dopaminergic; F-18-DOPA; compensatory mechanisms;
D O I
10.3389/fnsys.2011.00092
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of Parkinson's disease (PD) is characterized by focal motor features in one body part, which are usually correlated with greater dopaminergic depletion in the contralateral posterior putamen. The role of dopamine (DA) hemispheric differences in the onset and progression of motor symptoms of PD, however, remains undefined. Previous studies have demonstrated that unilateral manipulations of one nigrostriatal system affect contralateral DA turnover, indicating a functional and compensatory inter-dependence of the two nigrostriatal systems. In preliminary data obtained by our group from asymmetric PD patients, a higher asymmetry index as measured by 6-[F-18]fluoro-L-dopa (F-18-DOPA) positron emission tomography (PET) was associated with a higher threshold (i.e., greater dopaminergic loss) for the onset of motor symptoms in the less-affected side. To further elucidate the underlying basis for this, we carried out a complementary study in monkeys using PET to assess and correlate the degree of dopaminergic striatal depletion with motor activity. Control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys with symmetrical lesions were characterized behaviorally and with F-18-DOPA PET. In parallel, an acute lesion was inflicted in the nigrostriatal projection unilaterally in one monkey, generating a 30% dopaminergic depletion in the ipsilateral striatum, which was not associated with any noticeable parkinsonian feature or deficit. The monkey remained asymptomatic for several months. Subsequently, this monkey received systemic MPTP, following which motor behavior and PET were repeatedly evaluated during progression of parkinsonian signs. The brains of all monkeys were processed using immunohistochemical methods. Our results suggest that the onset of motor signs is related to and influenced by the dopaminergic status of the less-affected, contralateral striatum. Although this work is still preliminary, the study agrees with our general hypothesis of hemispheric inter-dependence in the compensation of striatal DA deficit in PD
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease
    Levandis, G.
    Balestra, B.
    Siani, F.
    Rizzo, V.
    Ghezzi, C.
    Ambrosi, G.
    Cerri, S.
    Bonizzi, A.
    Vicini, R.
    Vairetti, M.
    Ferrigno, A.
    Pastoris, O.
    Blandini, F.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (12): : 1783 - 1795
  • [22] Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries
    Tang, Chris C.
    Holtbernd, Florian
    Ma, Yilong
    Spetsieris, Phoebe
    Oh, Alice
    Fink, Gereon R.
    Timmermann, Lars
    Eggers, Carsten
    Eidelberg, David
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1737 - 1749
  • [23] Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
    Svenja Happe
    Paul Christian Baier
    Kathrin Helmschmied
    Johannes Meller
    Klaus Tatsch
    Walter Paulus
    Journal of Neurology, 2007, 254 : 1037 - 1043
  • [24] Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
    Happe, Svenja
    Baier, Paul Christian
    Helmschmied, Kathrin
    Meller, Johannes
    Tatsch, Klaus
    Paulus, Walter
    JOURNAL OF NEUROLOGY, 2007, 254 (08) : 1037 - 1043
  • [25] Dopaminergic modulation of motor network compensatory mechanisms in Parkinson's disease
    Jastrzebowska, Maya A.
    Marquis, Renaud
    Melie-Garcia, Lester
    Lutti, Antoine
    Kherif, Ferath
    Herzog, Michael H.
    Draganski, Bogdan
    HUMAN BRAIN MAPPING, 2019, 40 (15) : 4397 - 4416
  • [26] Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment
    Hirsch, EC
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S115 - S121
  • [27] Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
    Du, YS
    Ma, ZZ
    Lin, SZ
    Dodel, RC
    Gao, F
    Bales, KR
    Triarhou, LC
    Chernet, E
    Perry, KW
    Nelson, DLG
    Luecke, S
    Phebus, LA
    Bymaster, FP
    Paul, SM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14669 - 14674
  • [28] Relationship between nigrostriatal dopaminergic degeneration and urinary symptoms in Parkinson's disease
    Winge, K
    Friberg, L
    Werdelin, L
    Nielsen, KK
    Stimpel, H
    MOVEMENT DISORDERS, 2004, 19 : S210 - S210
  • [29] Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
    Machado, A.
    Herrera, A. J.
    Venero, J. L.
    Santiago, M.
    De Pablos, R. M.
    Villaran, R. F.
    Espinosa-Oliva, A. M.
    Argueelles, S.
    Sarmiento, M.
    Delgado-Cortes, M. J.
    Maurino, R.
    Cano, J.
    PARKINSONS DISEASE, 2011, 2011
  • [30] Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
    Rizelio, V.
    Szawka, R. E.
    Xavier, L. L.
    Achaval, M.
    Rigon, P.
    Saur, L.
    Matheussi, F.
    Delattre, A. M.
    Anselmo-Franci, J. A.
    Meneses, M.
    Ferraz, A. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (01) : 85 - 95